Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $272,651.64 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 492 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $554.17, for a total transaction of $272,651.64. Following the completion of the sale, the senior vice president now owns 3,072 shares of the company’s stock, valued at approximately $1,702,410.24. The trade was a 13.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Mark Brosius also recently made the following trade(s):

• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The shares were sold at an average price of $573.78, for a total transaction of $282,299.76.

Intuitive Surgical Stock Down 3.8 %

Shares of ISRG stock opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $184.59 billion, a PE ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The firm has a 50 day moving average of $571.36 and a two-hundred day moving average of $531.53.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Finally, BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. Evercore ISI increased their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.